56
Participants
Start Date
April 17, 2020
Primary Completion Date
August 9, 2024
Study Completion Date
March 31, 2026
Darolutamide
Darolutamide at a dose of 600 mg (2 tablets of 300 mg) twice daily with food (equivalent to a daily dose of 1200 mg) will be administered orally.
Goserelin
Goserelin at a dose of 3.6 mg will be administered subcutaneously every 4 weeks.
Nagoya University Hospital, Nagoya
Chiba University Hospital, Chiba
National Cancer Center Hospital East, Kashiwa
National Hospital Organization Kyushu Medical Center, Fukuoka
Hokkaido University Hospital, Sapporo
Kobe University Hospital, Kobe
Yokohama City University Hospital, Yokohama
Tohoku University Hospital, Sendai
Osaka International Cancer Institute, Osaka
The Jikei University Hospital, Tokyo
Tokyo Medical And Dental University Hospital, Tokyo
Tokyo Medical University Hospital, Tokyo
Bayer Yakuhin, Ltd.
INDUSTRY
National Cancer Center Hospital East
OTHER